WAVE

Waverley Pharma (WAVE)

Waverley Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:TSXV:WAVE

일자	시간	출처	헤드라인	심볼	기업
2024/05/01	09:08	PR Newswire (Canada)	Waverley Pharma Business Update	TSXV:WAVE	Waverley Pharma Inc
2023/11/23	07:00	PR Newswire (Canada)	Waverley Pharma Announces Changes to Board of Directors	TSXV:WAVE	Waverley Pharma Inc
2023/08/03	05:37	PR Newswire (Canada)	Waverley Pharma Business Update	TSXV:WAVE	Waverley Pharma Inc
2023/03/20	20:55	PR Newswire (Canada)	Waverley Pharma Provides Business Update	TSXV:WAVE	Waverley Pharma Inc
2023/01/11	21:55	PR Newswire (Canada)	Waverley Pharma Provides Update on its PARP-1 Inhibitor Program	TSXV:WAVE	Waverley Pharma Inc
2021/08/05	21:05	PR Newswire (Canada)	Waverley Pharma Announces $3,000,000 Credit Facility	TSXV:WAVE	Waverley Pharma Inc
2021/05/27	21:05	PR Newswire (Canada)	Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS England	TSXV:WAVE	Waverley Pharma Inc
2021/01/18	22:40	PR Newswire (Canada)	Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS Scotland	TSXV:WAVE	Waverley Pharma Inc
2020/11/13	02:04	PR Newswire (Canada)	Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United States	TSXV:WAVE	Waverley Pharma Inc
2020/09/23	21:20	PR Newswire (Canada)	Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)	TSXV:WAVE	Waverley Pharma Inc
2020/09/08	23:13	PR Newswire (Canada)	Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the Un...	TSXV:WAVE	Waverley Pharma Inc
2020/08/25	21:15	PR Newswire (Canada)	Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy	TSXV:WAVE	Waverley Pharma Inc
2020/07/30	21:25	PR Newswire (Canada)	Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries	TSXV:WAVE	Waverley Pharma Inc
2020/06/25	21:15	PR Newswire (Canada)	Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Syn...	TSXV:WAVE	Waverley Pharma Inc
2020/04/29	05:53	PR Newswire (Canada)	Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial Statements	TSXV:WAVE	Waverley Pharma Inc
2020/02/03	22:15	PR Newswire (Canada)	Waverley Pharma Announces Appointment of New President and CEO	TSXV:WAVE	Waverley Pharma Inc
2020/01/09	07:09	PR Newswire (Canada)	Waverley Pharma Announces Executive Leadership Changes	TSXV:WAVE	Waverley Pharma Inc
2019/12/17	22:00	PR Newswire (Canada)	Waverley Pharma Announces Grant of Marketing Authorization in the United Kingdom for Erlotinib	TSXV:WAVE	Waverley Pharma Inc
2019/03/11	21:25	PR Newswire (Canada)	Waverley Pharma Provides Market Update and Fiscal 2018 Preliminary Revenue	TSXV:WAVE	Waverley Pharma Inc
2018/12/18	22:25	PR Newswire (Canada)	Waverley Pharma Announces Distribution Agreement and First Sale of Generic Oncology Products in the United Kingdom	TSXV:WAVE	Waverley Pharma Inc
2018/07/23	21:35	PR Newswire (Canada)	Waverley Pharma Announces Resignation of CEO and Appointment of New CEO	TSXV:WAVE	Waverley Pharma Inc
2018/06/27	21:35	PR Newswire (Canada)	Waverley Pharma Announces Filing of Two Abbreviated New Drug Applications in the United States	TSXV:WAVE	Waverley Pharma Inc
2018/06/25	21:30	PR Newswire (Canada)	Waverley Pharma Announces Acquisition of two Generic Oncology Products Currently Marketed in the United Kingdom	TSXV:WAVE	Waverley Pharma Inc
2018/04/17	21:30	PR Newswire (Canada)	Waverley Pharma Announces Filing of its Second Marketing Authorization Application in Select European Union Countries	TSXV:WAVE	Waverley Pharma Inc
2018/03/12	22:00	PR Newswire (Canada)	Waverley Pharma Announces Filing of Marketing Authorization Application in Select European Union Countries	TSXV:WAVE	Waverley Pharma Inc
2017/10/27	23:01	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - WAVE (anciennement BUFF.P)	TSXV:WAVE	Waverley Pharma Inc
2017/10/27	22:59	PR Newswire (Canada)	IIROC Trading Resumption - WAVE (Formerly BUFF.P)	TSXV:WAVE	Waverley Pharma Inc